Cargando…
Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer’s Disease in the Context of the COVID-19 Pandemic
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of the 2019 coronavirus disease (COVID-19), has affected more than 20 million people in Brazil and caused a global health emergency. This virus has the potential to affect various parts of the body and compromise metab...
Autores principales: | Simões, Júlia L.B., Sobierai, Leilane D., Leal, Inayá F., Dos Santos, Miriam V.R., Coiado, João Victor, Bagatini, Margarete D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IBRO. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746135/ https://www.ncbi.nlm.nih.gov/pubmed/36526078 http://dx.doi.org/10.1016/j.neuroscience.2022.12.007 |
Ejemplares similares
-
Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection
por: Simões, Júlia Leão Batista, et al.
Publicado: (2021) -
Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome
por: Simões, Júlia Leão Batista, et al.
Publicado: (2021) -
Novel possibility for cutaneous melanoma treatment by means of rosmarinic acid action on purinergic signaling
por: da Silva, Gilnei Bruno, et al.
Publicado: (2021) -
Editorial: Purinergic signaling and neuroinflammation
por: Assmann, Charles Elias, et al.
Publicado: (2022) -
Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2
por: dos Anjos, Fernanda, et al.
Publicado: (2020)